The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...

The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...

“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

Researchers make promising breakthrough in Alzheimer’s drug development: Lancaster Monday, October 7, 2024, 11:00 Hrs [IST] An international team of researchers led by Lancaster ...

A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...

Scientists have announced a significant breakthrough in the development of a drug to combat Alzheimer's disease. The drug, ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...

This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...